How to take dasatinib

Dasatinib is a targeted drug used to treat chronic myeloid leukemia (CML), especially for those patients with Philadelphia chromosome-positive (Ph+) CML who are resistant or intolerant to imatinib mesylate. It inhibits the activity of BCR-ABL tyrosine kinase and effectively blocks the abnormal proliferation signals of leukemia cells, thereby achieving the purpose of treating the disease.

Regarding the method of taking dasatinib, patients need to strictly follow the doctor's instructions to ensure the efficacy and safety of the drug. First, dasatinib can be taken orally and can be taken before or after meals. If patients experience gastrointestinal discomfort during taking, they can choose to take it with food to relieve discomfort. Secondly, dasatinib tablets must be swallowed whole and must not be broken, crushed or chewed to avoid affecting the absorption and efficacy of the drug. Patients who have difficulty swallowing should consult their doctor for professional medication advice.

In terms of dosage, the dosage of dasatinib will be adjusted according to the patient's specific condition and response. In general, for patients with Ph+ chronic phase CML, the recommended starting dose is 100 mg once daily. For CML patients in the Ph+ accelerated phase and blast phase (myeloid blast and blast phase), the recommended starting dose is 70 mg twice a day, taken in the morning and evening. If a patient fails to achieve desired results at the recommended starting dose, the doctor may consider increasing the dose, but this must be done under close monitoring by the doctor.

In addition, patients should pay attention to maintaining good living and eating habits while taking dasatinib, and avoid overexertion and spicy food. At the same time, patients should also undergo regular blood tests, liver and kidney function and other related tests to evaluate the efficacy and safety of the drug. If any discomfort or unusual symptoms occur, patients should seek medical advice immediately and inform their doctor that they are taking dasatinib.

In short, the method of taking dasatinib must strictly follow the doctor's instructions to ensure the efficacy and safety of the drug. Patients should pay close attention to their body's reaction during medication and conduct relevant examinations regularly.